Science Explorer Back to mapMap
Discussion
Institution · Catalyst Pharmaceuticals (United States)

Most cited papers from Catalyst Pharmaceuticals (United States)

Catalyst Pharmaceuticals (United States)

What are the most cited papers from Catalyst Pharmaceuticals (United States)?

The most cited paper from Catalyst Pharmaceuticals (United States) is "Habits and Goals in Human Behavior: Separate but Interacting Systems" (Wendy Wood, Asaf Mazar, David T. Neal, 2021), with 145 citations. Next come "Computational methods for case-cohort studies" (128) and "(1S, 3S)-3-Amino-4-difluoromethylenyl-1-cyclopentanoic Acid (CPP-115), a Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Cocaine Addiction" (52).

Showing 28 of 28 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Habits and Goals in Human Behavior: Separate but Interacting Systems Wendy Wood, Asaf Mazar, David T. Neal · Perspectives on Psychological Science 20 Jul 2021 145
2 Computational methods for case-cohort studies Bryan M. Langholz, Jenny Jiao · Computational Statistics & Data Analysis 23 Dec 2006 128
3 (1S, 3S)-3-Amino-4-difluoromethylenyl-1-cyclopentanoic Acid (CPP-115), a Potent γ-Aminobutyric Acid Aminotransferase Inactivator for the Treatment of Cocaine Addiction Yue Pan, Madina R. Gerasimov, Trine Kvist et al. · Journal of Medicinal Chemistry Open access 30 Nov 2011 52
4 A Multisite, Double-blind, Placebo-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Vigabatrin for Treating Cocaine Dependence Eugene C. Somoza, Douglas Winship, Charles W. Gorodetzky et al. · JAMA Psychiatry 10 Apr 2013 47
5 The Novel Phosphodiesterase Inhibitor NM-702 Improves Claudication-Limited Exercise Performance in Patients With Peripheral Arterial Disease Eric P. Brass, Richard M. Anthony, Frederick R. Cobb et al. · Journal of the American College of Cardiology Open access 29 Nov 2006 36
6 Risk management and post-marketing surveillance for the abuse of medications acting on the central nervous system: Expert Panel Report Chris‐Ellyn Johanson, Robert L. Balster, Jack E. Henningfield et al. · Drug and Alcohol Dependence Open access 24 Sep 2009 26
7 Optimal assessment of baseline treadmill walking performance in claudication clinical trials Eric P. Brass, Jenny Jiao, William R. Hiatt · Vascular Medicine May 2007 15
8 Amifampridine safety and efficacy in spinal muscular atrophy ambulatory patients: a randomized, placebo-controlled, crossover phase 2 trial Silvia Bonanno, Riccardo Giossi, Riccardo Zanin et al. · Journal of Neurology Open access 28 Jun 2022 12
9 Visual Field and Ocular Safety During Short-Term Vigabatrin Treatment in Cocaine Abusers Tamara L. Berezina, Albert S Khouri, M. Douglas Winship et al. · American Journal of Ophthalmology 15 Jun 2012 12
10 Acetylator Status Impacts Amifampridine Phosphate (Firdapse™) Pharmacokinetics and Exposure to a Greater Extent Than Renal Function Peter E. Haroldsen, Zlatko Sisic, Joe Datt et al. · Clinical Therapeutics Open access 20 Jun 2017 10
11 Two-Dimensional Proton Magnetic Resonance Spectroscopy versus J-Editing for GABA Quantification in Human Brain: Insights from a GABA-Aminotransferase Inhibitor Study Andrew P. Prescot, James J. Prisciandaro, S.R. Miller et al. · Scientific Reports Open access 29 Aug 2018 8
12 Marked reduction in paralytic attacks in a patient with Andersen-Tawil syndrome switched from acetazolamide to dichlorphenamide Anirudh Gupta, Stanley Jones P. Iyadurai, Jennifer Roggenbuck et al. · Neuromuscular Disorders Open access 24 Apr 2021 7
13 In Vivo Detection of CPP-115 Target Engagement in Human Brain Andrew P. Prescot, S.R. Miller, Gary G. Ingenito et al. · Neuropsychopharmacology Open access 25 Jul 2017 7
14 Therapeutic efficacy of 3,4-Diaminopyridine phosphate on neuromuscular junction in Pompe disease Cinzia Bragato, Flavia Blàsevich, Gary G. Ingenito et al. · Biomedicine & Pharmacotherapy Open access 21 Feb 2021 6
15 Marked under-diagnosis of Lambert-Eaton myasthenic syndrome in small cell lung cancer: an analysis of real-world claims data Benjamin Jacob Drapkin, David J. Morrell, Regina C. Grebla et al. · Frontiers in Oncology Open access 17 Oct 2025 2
16 P2.31-03 Lambert-Eaton Myasthenic Syndrome is Underrecognized in Small Cell Lung Cancer: An Analysis of Real-World Data David F. Morrell, Benjamin Jacob Drapkin, Gilad Shechter et al. · Journal of Thoracic Oncology Open access 31 Oct 2023 2
17 A response to a recent editorial by concerned physicians on 3,4‐diaminopyridine Patrick J. McEnany · Muscle & Nerve Open access 18 Oct 2016 1
18 Amifampridine phosphate (FirdapseTM) is safe and effective in a pivotal Phase 3 trial in LEMS patients. (PL2.001) Shin Joong Oh, Charles W. Gorodetzky, Douglas Winship · Neurology 6 Apr 2015 1
19 HSR26-256: Real-World Evidence of Predictors of Time to Amifampridine Discontinuation and Survival in Patients With Cancer–Associated and Non-Cancer–Associated Lambert-Eaton Myasthenic Syndrome in the United States Jennifer Wilkinson Carlisle, Steven D. Woods, Reid Badgett et al. · Journal of the National Comprehensive Cancer Network 27 Mar 2026 0
20 EP.17A.06 Real-World Trends in Screening and Evaluation of Paraneoplastic Syndromes among Patients with Small Cell Lung Cancer Gilad Shechter, David F. Morrell, Regina C. Grebla et al. · Journal of Thoracic Oncology Open access Oct 2024 0
21 Diagnosis of Lambert-Eaton Myasthenic Syndrome (LEMS) May Be Missed Among Patients with Myasthenia Gravis and Autonomic Dysfunction: Results from a US Database Analysis (P4-11.018) Steven A. Vernino, David Morrell, Guy Shechter et al. · Neurology 9 Apr 2024 0
22 HSR24-169: Autonomic Symptoms May Suggest Paraneoplastic Neurological Syndromes in Small Cell Lung Cancer Guy Shechter, David Morrell, Regina C. Grebla et al. · Journal of the National Comprehensive Cancer Network 5 Apr 2024 0
23 Lofexidine Charles W. Gorodetzky, Kristen L. Gullo, Marc J. Fishman · Oxford University Press eBooks Book chapter 22 May 2023 0
24 Immune Neuropathies Stanley Jones P. Iyadurai, Darine Kassar Book chapter 2022 0
25 Effect of 3,4-diaminopyridine phosphate in symptomatic SOD1-G93A mice Swathi Beladakere Ramaswamy, John A. Stanford, Stanley Jones P. Iyadurai et al. · RRNMF Neuromuscular Journal Open access 11 Mar 2022 0
26 Peripheral Visual Field (PVF) Testing in Subjects That Abuse Cocaine R. D. Fechtner, Tamara L. Berezina, Albert S Khouri et al. · Investigative Ophthalmology & Visual Science 17 Apr 2010 0
27 Oral vs. intraperitoneal dosing in the rat drug discrimination model Michela Tessari, Beatrice Compagnucci, Benedetta Spurio et al. · Journal of Pharmacological and Toxicological Methods Sep 2019 0
28 Peripheral Visual Field (PVF) Monitoring During Short Term Vigabatrin Treatment in Cocaine Abusers Tamara L. Berezina, Albert S Khouri, M. Douglas Winship et al. · Investigative Ophthalmology & Visual Science 22 Apr 2011 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.